Meanwhile, lower MRC2 was associated with worse DFS in LGG (p = 0.013) and PAAD (p = 0.036) (Supplementary Figures S2A,C), worse DSS in BLCA (p = 0.029), LGG (p < 0.001), KIRC (p = 0.003), and UVM (p < 0.001) (Supplementary Figures S3B–E), worse PFS in COAD (p = 0.014), KIRC (p < 0.001), LGG (p < 0.001), and UVM (p < 0.001), and better PFS in only DLBC(p = 0.016) (Supplementary Figures S4B–F). This evidence concerns the gene MRC2 and bladder transitional cell carcinoma.